BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24445144)

  • 21. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retina regeneration in the chick embryo is not induced by spontaneous Mitf downregulation but requires FGF/FGFR/MEK/Erk dependent upregulation of Pax6.
    Spence JR; Madhavan M; Aycinena JC; Del Rio-Tsonis K
    Mol Vis; 2007 Jan; 13():57-65. PubMed ID: 17277739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytes.
    Yan D; Chen D; Im HJ
    J Cell Biochem; 2012 Sep; 113(9):2856-65. PubMed ID: 22488450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-2 up-regulates the expression of nestin through the Ras-Raf-ERK-Sp1 signaling axis in C6 glioma cells.
    Chang KW; Huang YL; Wong ZR; Su PH; Huang BM; Ju TK; Yang HY
    Biochem Biophys Res Commun; 2013 May; 434(4):854-60. PubMed ID: 23611784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
    Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
    Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells.
    Ma C; Bower KA; Chen G; Shi X; Ke ZJ; Luo J
    J Biol Chem; 2008 Apr; 283(14):9248-56. PubMed ID: 18263590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells.
    Rauch BH; Millette E; Kenagy RD; Daum G; Fischer JW; Clowes AW
    J Biol Chem; 2005 Apr; 280(17):17507-11. PubMed ID: 15731100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer.
    Liu L; Zhang H; Sun L; Gao Y; Jin H; Liang S; Wang Y; Dong M; Shi Y; Li Z; Fan D
    Int J Cancer; 2010 Aug; 127(4):820-9. PubMed ID: 19998339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1.
    Finetti F; Solito R; Morbidelli L; Giachetti A; Ziche M; Donnini S
    J Biol Chem; 2008 Jan; 283(4):2139-46. PubMed ID: 18042549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.
    Sheppard HE; Dall'Agnese A; Park WD; Shamim MH; Dubrulle J; Johnson HL; Stossi F; Cogswell P; Sommer J; Levy J; Sharifnia T; Wawer MJ; Nabet B; Gray NS; Clemons PA; Schreiber SL; Workman P; Young RA; Lin CY
    Cell Rep Med; 2021 Jan; 2(1):100188. PubMed ID: 33521702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
    Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
    Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats.
    Li ZY; Huang Y; Yang YT; Zhang D; Zhao Y; Hong J; Liu J; Wu LJ; Zhang CH; Wu HG; Zhang J; Ma XP
    World J Gastroenterol; 2017 Sep; 23(34):6220-6230. PubMed ID: 28974888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1.
    Yang H; Xia Y; Lu SQ; Soong TW; Feng ZW
    J Biol Chem; 2008 Feb; 283(9):5287-95. PubMed ID: 18171671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 2 applied to the optic nerve after axotomy increases Bcl-2 and decreases Bax in ganglion cells by activating the extracellular signal-regulated kinase signaling pathway.
    Ríos-Muñoz W; Soto I; Duprey-Díaz MV; Blagburn J; Blanco RE
    J Neurochem; 2005 Jun; 93(6):1422-33. PubMed ID: 15935058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
    Dell'Era P; Mohammadi M; Presta M
    Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of lipid phosphate phosphatase activity by VPC32183 suppresses the ability of diacylglycerol pyrophosphate to activate ERK(1/2) MAP kinases.
    Violet PC; Billon-Denis E; Robin P
    Biochim Biophys Acta; 2012 Nov; 1821(11):1394-405. PubMed ID: 22820196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
    Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
    Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.